Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Aug 28, 2023 5:42pm
238 Views
Post# 35608872

RE:RE:RE:Interim Data...

RE:RE:RE:Interim Data...

Funny, it's the same that now whine about small pps that were requesting them in 2016, 2017, 2018, 2019!

Hey, I can even bet that once we have a deal, no matter what it is, the same ones will still whine, say this is not enough, etc ...

A classic, coming from the same that clearly don't understand the environment they're invested in, when you read their posts.  Like we should have been worth 1-2$ a share back in 2016 (while we didn't even receive a HC approval and neither had a drug manufacturer), etc ...

Nothing that has been accomplished so far, we owe it to those whiners.  Nothing.  And we're knocking at the door of FDA Breakthrough designation.  We're privileged to be in a disruptive oncology stock at this price.  You'd think these whiners would have entered in this stock @25$ while the stock would trade ar current share price!

Funny that these whiners always appear ahead of financials.  That's another classic.





 


___________

 

RE:RE:Interim Data...
Frankly,  I don't expect major jump in share prices as long as Roger keeps talking about Cheap PP at $ 0.25 for his select group of buddies.  The clinical results will make a short term swing up which will be brought down as soon as RDW starts talking about his 25 cent PP.   
The Pumpers and spin Doctors will continue with their expert opinion.  Nothing prophecied on this board really matters.  RDW will keep extending the timeline.  Our Board of Directors do not seem to have any real say in the Management.   I will continue to hold my position and get out at the right time.  May even come back next year and check out this board just for entertainment and find a new set of Pumpers and experts
<< Previous
Bullboard Posts
Next >>